U.S. Artemisinic Acid Market Size, Share & Trends Analysis Report By Product (Antimalarial Injections, Antimalarial Tablets), And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. U.S. Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Artemisinic Acid Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. U.S. Artemisinic Acid Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework

Chapter 4. U.S. Artemisinic Acid Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Artemisinic Acid Market: Product Movement Analysis
• 4.3. U.S. Artemisinic Acid Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
• 4.4. Antimalarial Tablets
  • 4.4.1. Antimalarial Tablets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Antimalarial Injections
  • 4.5.1. Antimalarial Injections Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Market Participant Categorization
• 5.2. Company Market Position Analysis/ Heap Map Analysis
• 5.3. Company Profiles
  • 5.3.1. Sanofi
    • 5.3.1.1. Participant's Overview
    • 5.3.1.2. Financial Performance
    • 5.3.1.3. Product Benchmarking
    • 5.3.1.4. Strategic Initiatives
  • 5.3.2. KPC Pharmaceuticals, Inc.
    • 5.3.2.1. Participant's Overview
    • 5.3.2.2. Financial Performance
    • 5.3.2.3. Product Benchmarking
    • 5.3.2.4. Strategic Initiatives
  • 5.3.3. Guilin Pharmaceuticals Co,. Ltd.
    • 5.3.3.1. Participant's Overview
    • 5.3.3.2. Financial Performance
    • 5.3.3.3. Product Benchmarking
    • 5.3.3.4. Strategic Initiatives
  • 5.3.4. Calyx Chemicals and Pharmaceuticals Ltd.
    • 5.3.4.1. Participant's Overview
    • 5.3.4.2. Financial Performance
    • 5.3.4.3. Product Benchmarking
    • 5.3.4.4. Strategic Initiatives
  • 5.3.5. Novartis Pharmaceuticals Corporation
    • 5.3.5.1. Participant's Overview
    • 5.3.5.2. Financial Performance
    • 5.3.5.3. Product Benchmarking
    • 5.3.5.4. Strategic Initiatives
  • 5.3.6. Ipca Laboratories Inc.
    • 5.3.6.1. Participant's Overview
    • 5.3.6.2. Financial Performance
    • 5.3.6.3. Product Benchmarking
    • 5.3.6.4. Strategic Initiatives
  • 5.3.7. Cipla USA Inc.
    • 5.3.7.1. Participant's Overview
    • 5.3.7.2. Financial Performance
    • 5.3.7.3. Product Benchmarking
    • 5.3.7.4. Strategic Initiatives
  • 5.3.8. SHINPOONG CO. Ltd.
    • 5.3.8.1. Participant's Overview
    • 5.3.8.2. Financial Performance
    • 5.3.8.3. Product Benchmarking
    • 5.3.8.4. Strategic Initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 U.S. Artemisinic Acid Market, by Product, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. artemisinic acid market revenue, 2021 - 2033 (USD Million)
• Fig. 10 U.S. artemisinic acid market snapshot
• Fig. 11 U.S. artemisinic acid market driver impact
• Fig. 12 U.S. artemisinic acid market restraint impact
• Fig. 13 U.S. artemisinic acid market product key takeaways (USD Million)
• Fig. 14 U.S. artemisinic acid market : Product movement analysis
• Fig. 15 Antimalarial injections market, 2021 - 2033 (USD Million)
• Fig. 16 Antimalarial tablets market, 2021 - 2033 (USD Million)
• Fig. 17 Market participant categorization